Patch testing in aesthetics: when, why, and the record to keep

A patch test is required wherever the product you are applying carries a known sensitisation risk and the manufacturer or your insurer says so. In practice that means lash and brow tints almost always, certain topical products and devices sometimes, and injectables generally not, although your insurance policy can override convention entirely. The two questions to ask before any treatment are: what do the manufacturer’s instructions say, and what does my policy wording say. If either requires a patch test, the conversation is over and the test happens.

Checked against official sources at the date shown above. Regulation moves; if you spot something out of date, email [email protected] and we will correct it.

Which treatments conventionally require a patch test

The clearest case is tinting. Lash and brow tints commonly contain paraphenylenediamine (PPD) or related dye intermediates, which are well-documented sensitisers. Reactions around the eye are not a cosmetic inconvenience; severe responses can involve significant swelling and, in the worst cases, emergency care. Manufacturers of professional tint products build patch testing into their instructions for use, and following those instructions is part of using the product lawfully and defensibly. The same logic extends to lash lift systems and adhesives, where the chemistry differs but the sensitisation principle is the same.

Beyond tinting, patch testing conventions apply to:

• Some topical products, particularly where a client reports sensitive skin, a history of allergy, or where the manufacturer’s instructions call for a test application.
• Certain energy devices. Laser and IPL protocols typically include a test patch on the treatment area, days before the first full session, to observe the skin’s response. This is a different exercise from an allergy patch test, but the documentation discipline is identical.
• Hair removal chemistry such as waxes with new clients who report sensitivities, where many insurers and manufacturers advise a test.

The common thread is not the treatment category. It is the combination of a known reaction risk, a manufacturer instruction, and an insurer expectation.

Where injectables sit

Botulinum toxin and hyaluronic acid dermal fillers are not conventionally patch tested. There is no standard pre-treatment skin test for these products in routine UK practice, and manufacturers do not generally require one. That does not make injectables low-stakes; it means the risk is managed differently, through medical history screening, prescriber assessment and informed consent rather than a forearm test. A thorough medical history form does for injectables what a patch test does for tints: it surfaces the contraindication before the product does.

Be careful with absolute statements, though. Some products on the fringes of the injectable market, and some older filler types, have carried test-dose recommendations. Read the instructions for use for every product you stock, every time the manufacturer revises them.

Your insurer may not care about convention

This is the part that catches practitioners out. Insurance policies frequently impose patch testing requirements that go beyond manufacturer instructions, and the consequences of ignoring them are severe: insurers can decline a claim where a documented patch test was a policy condition and you cannot produce the record. At that point you are personally exposed on a claim that your premium was supposed to cover.

So do not work from a generic industry summary, including this one. Pull your actual policy wording and find the patch testing clause. Note which treatments it covers, the required interval before treatment, how often tests must be repeated (some policies require a fresh test after a defined gap between appointments, or whenever the product or the client’s medical status changes), and what record it expects. If anything is ambiguous, get the insurer’s answer in writing. Our guide to aesthetics insurance covers how to read a policy properly.

Timing: the 24 to 48 hour convention

The widely used convention is to perform the patch test 24 to 48 hours before treatment, with 48 hours the safer and more commonly specified figure. The reason is pharmacological rather than administrative: the allergic responses of most concern are delayed-type hypersensitivity reactions, which can take a day or two to develop fully. A test read at two hours can look clear and still precede a significant reaction. Follow the specific interval in the manufacturer’s instructions and your policy; where they differ, apply the stricter one.

A patch test is also not a lifetime pass. Sensitisation can develop with repeated exposure, which is precisely how PPD allergy tends to arise. Treat a previous clear test as evidence about the past, not a guarantee about the future, and re-test on the schedule your insurer and the manufacturer set.

How to record a patch test properly

An undocumented patch test might as well not have happened. The record is what your insurer, and in a bad scenario a solicitor, will ask for. Capture, at minimum:

• Date and time of application, and of the result reading.
• Product details: brand, product name, shade where relevant, and the batch number. Batch numbers matter because reactions are sometimes traced to specific production runs.
• Test site: typically the inner forearm or behind the ear, recorded specifically.
• Method: what was applied, in what quantity or mix, per which instructions.
• Result: a clear positive or negative, with a description of any response observed, however mild.
• Signatures: the practitioner who applied and read the test, and the client confirming the outcome and any advice given.

Keep the record with the client’s treatment file, not on a loose card. The treatment record template shows the structure, and a system that timestamps entries and links them to the client record is worth more than any paper logbook when a claim is years old.

When a client refuses

Clients will push back, usually because a 48 hour lead time is inconvenient. Where a patch test is required by the manufacturer or your policy, refusal ends the booking. Performing the treatment anyway means working outside the product’s instructions and probably outside your insurance, and a signed waiver does not fix that: a disclaimer cannot reinstate cover your policy has excluded, and it is weak protection against a negligence claim.

Handle it commercially rather than confrontationally. Build the patch test into the booking flow for first appointments, offer a quick drop-in slot for the test itself, and explain that the rule exists because reactions to these products are real. Document the refusal if a client declines and walks away; a short note that the test was offered, the reason was explained, and the treatment was therefore not performed is the final entry that protects you.

This guide is general information, not legal advice.